Lawrence A. Kenyon
2017
In 2017, Lawrence A. Kenyon earned a total compensation of $595K as Director, Chief Executive Officer, President, Chief Financial Officer, Treasurer and Corporate Secretary at Outlook Therapeutics, a 63% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Salary | $350,000 |
| Stock Awards | $128,065 |
| Other | $16,940 |
| Total | $595,005 |
Kenyon received $350K in salary, accounting for 59% of the total pay in 2017.
Kenyon also received $100K in bonus, $128.1K in stock awards and $16.9K in other compensation.
Rankings
In 2017, Lawrence A. Kenyon's compensation ranked 11,235th out of 14,666 executives tracked by ExecPay. In other words, Kenyon earned more than 23.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,235 out of 14,666 | 23rd |
Division Manufacturing | 4,404 out of 5,772 | 24th |
Major group Chemicals And Allied Products | 1,601 out of 2,075 | 23rd |
Industry group Drugs | 1,319 out of 1,731 | 24th |
Industry Biological Products, Except Diagnostic Substances | 233 out of 313 | 26th |
Source: SEC filing on August 17, 2018.
Kenyon's colleagues
We found two more compensation records of executives who worked with Lawrence A. Kenyon at Outlook Therapeutics in 2017.